380 related articles for article (PubMed ID: 19519301)
1. A common biological mechanism in cancer and Alzheimer's disease?
Behrens MI; Lendon C; Roe CM
Curr Alzheimer Res; 2009 Jun; 6(3):196-204. PubMed ID: 19519301
[TBL] [Abstract][Full Text] [Related]
2. A common molecular and cellular pathway in developing Alzheimer and cancer.
Ali M; Wani SUD; Dey T; Sridhar SB; Qadrie ZL
Biochem Biophys Rep; 2024 Mar; 37():101625. PubMed ID: 38225990
[TBL] [Abstract][Full Text] [Related]
3. Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.
Lanni C; Masi M; Racchi M; Govoni S
Mol Psychiatry; 2021 Jan; 26(1):280-295. PubMed ID: 32382138
[TBL] [Abstract][Full Text] [Related]
4. The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?
Caricasole A; Copani A; Caruso A; Caraci F; Iacovelli L; Sortino MA; Terstappen GC; Nicoletti F
Trends Pharmacol Sci; 2003 May; 24(5):233-8. PubMed ID: 12767722
[TBL] [Abstract][Full Text] [Related]
5. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
6. Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.
Driver JA; Zhou XZ; Lu KP
Biochim Biophys Acta; 2015 Oct; 1850(10):2069-76. PubMed ID: 25583562
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease.
da Cruz e Silva OA; Henriques AG; Domingues SC; da Cruz e Silva EF
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):720-6. PubMed ID: 20942790
[TBL] [Abstract][Full Text] [Related]
8. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
9. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
[TBL] [Abstract][Full Text] [Related]
10. Pin1: a new genetic link between Alzheimer's disease, cancer and aging.
Driver JA; Lu KP
Curr Aging Sci; 2010 Dec; 3(3):158-65. PubMed ID: 20735350
[TBL] [Abstract][Full Text] [Related]
11. SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.
Shen Y; Xia Y; Meng S; Lim NK; Wang W; Huang F
J Alzheimers Dis; 2017; 55(2):835-847. PubMed ID: 27802221
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
Inestrosa NC; Urra S; Colombres M
Curr Alzheimer Res; 2004 Nov; 1(4):249-54. PubMed ID: 15975054
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
17. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
19. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.
Inestrosa NC; Varela-Nallar L; Grabowski CP; Colombres M
IUBMB Life; 2007; 59(4-5):316-21. PubMed ID: 17505971
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
Shafi O
BMC Neurol; 2016 Nov; 16(1):236. PubMed ID: 27875990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
